Neximmune Inc

-1.46 (-8.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Neximmune Inc Stock, NASDAQ:NEXI

9119 Gaither Road, Gaithersburg, Maryland 20877
United States of America
Phone: +1.301.685.1688
Number of Employees: 44


NexImmune, Inc. engages in the development of novel approach to immunotheraphy designed to create therapies with curative potential for patients with cancer and other life threatening immune-mediated diseases. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke in June 7, 2011 and is headquartered in Gaithersburg, MD.